Sudden Sensorineural Hearing Loss in Hemodialysis Patients Could be a Marker of Pathogenic Progression in the Mortality and Atherosclerotic Events: A National Cohort Study

Chu Lin Chou, Tsung Cheng Hsieh, Jin Shuen Chen, Te Chao Fang

Research output: Contribution to journalArticle

Abstract

OBJECTIVES: There are higher incidence of sudden sensorineural hearing loss (SSHL) in hemodialysis (HD) patients than in the general population. Long-term outcomes of HD patients with new-onset SSHL have yet to be investigated although SSHL is considered as an independent risk of cardiovascular diseases in the general population. We examined the risks of mortality and atherosclerotic events in HD patients with new-onset SSHL in Taiwan. STUDY DESIGN: Cohort study. METHODS: Using the Taiwan National Health Institutes Research Database, 105,243 HD patients were identified between 1997 and 2008. In total, 288 HD patients with a new diagnosis of idiopathic SSHL were enrolled and matched with 1,728 HD patients without SSHL by using propensity score matching at a ratio of 1:6. MAIN OUTCOME MEASURES: A multivariate Cox regression and a competing risk regression were used to evaluate mortality and atherosclerotic events. RESULTS: Results revealed a risk of mortality in HD patients with SSHL than in HD patients without SSHL (adjusted hazard ratios [aHRs] 2.22, 95% confidence interval [CI] 1.71-2.89). HD patients with SSHL had higher risks of hemorrhagic stroke (competing risk aHR 4.08, 95% CI 1.93-8.61), ischemic stroke (competing risk aHR 2.34, 95% CI 1.45-3.78), acute coronary syndrome, and peripheral arterial occlusive disease than did the HD patients without SSHL. CONCLUSION: This study is the first to signify that the risks of mortality and atherosclerotic complications in HD patients with new-onset SSHL are increased. Therefore, we should pay attention to risks of mortality and atherosclerotic events in HD patients with new-onset SSHL.

Original languageEnglish
Pages (from-to)1241-1249
Number of pages9
JournalOtology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
Volume39
Issue number10
DOIs
Publication statusPublished - Dec 1 2018

Fingerprint

Sudden Hearing Loss
Sensorineural Hearing Loss
Renal Dialysis
Cohort Studies
Mortality
Confidence Intervals
Taiwan
Stroke
Arterial Occlusive Diseases
Propensity Score
Peripheral Arterial Disease
National Institutes of Health (U.S.)
Acute Coronary Syndrome
Population
Cardiovascular Diseases

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Sensory Systems
  • Clinical Neurology

Cite this

@article{5d4b9f577ef345f991dab613bcd1f0ea,
title = "Sudden Sensorineural Hearing Loss in Hemodialysis Patients Could be a Marker of Pathogenic Progression in the Mortality and Atherosclerotic Events: A National Cohort Study",
abstract = "OBJECTIVES: There are higher incidence of sudden sensorineural hearing loss (SSHL) in hemodialysis (HD) patients than in the general population. Long-term outcomes of HD patients with new-onset SSHL have yet to be investigated although SSHL is considered as an independent risk of cardiovascular diseases in the general population. We examined the risks of mortality and atherosclerotic events in HD patients with new-onset SSHL in Taiwan. STUDY DESIGN: Cohort study. METHODS: Using the Taiwan National Health Institutes Research Database, 105,243 HD patients were identified between 1997 and 2008. In total, 288 HD patients with a new diagnosis of idiopathic SSHL were enrolled and matched with 1,728 HD patients without SSHL by using propensity score matching at a ratio of 1:6. MAIN OUTCOME MEASURES: A multivariate Cox regression and a competing risk regression were used to evaluate mortality and atherosclerotic events. RESULTS: Results revealed a risk of mortality in HD patients with SSHL than in HD patients without SSHL (adjusted hazard ratios [aHRs] 2.22, 95{\%} confidence interval [CI] 1.71-2.89). HD patients with SSHL had higher risks of hemorrhagic stroke (competing risk aHR 4.08, 95{\%} CI 1.93-8.61), ischemic stroke (competing risk aHR 2.34, 95{\%} CI 1.45-3.78), acute coronary syndrome, and peripheral arterial occlusive disease than did the HD patients without SSHL. CONCLUSION: This study is the first to signify that the risks of mortality and atherosclerotic complications in HD patients with new-onset SSHL are increased. Therefore, we should pay attention to risks of mortality and atherosclerotic events in HD patients with new-onset SSHL.",
author = "Chou, {Chu Lin} and Hsieh, {Tsung Cheng} and Chen, {Jin Shuen} and Fang, {Te Chao}",
year = "2018",
month = "12",
day = "1",
doi = "10.1097/MAO.0000000000001967",
language = "English",
volume = "39",
pages = "1241--1249",
journal = "Otology and Neurotology",
issn = "1531-7129",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

TY - JOUR

T1 - Sudden Sensorineural Hearing Loss in Hemodialysis Patients Could be a Marker of Pathogenic Progression in the Mortality and Atherosclerotic Events

T2 - A National Cohort Study

AU - Chou, Chu Lin

AU - Hsieh, Tsung Cheng

AU - Chen, Jin Shuen

AU - Fang, Te Chao

PY - 2018/12/1

Y1 - 2018/12/1

N2 - OBJECTIVES: There are higher incidence of sudden sensorineural hearing loss (SSHL) in hemodialysis (HD) patients than in the general population. Long-term outcomes of HD patients with new-onset SSHL have yet to be investigated although SSHL is considered as an independent risk of cardiovascular diseases in the general population. We examined the risks of mortality and atherosclerotic events in HD patients with new-onset SSHL in Taiwan. STUDY DESIGN: Cohort study. METHODS: Using the Taiwan National Health Institutes Research Database, 105,243 HD patients were identified between 1997 and 2008. In total, 288 HD patients with a new diagnosis of idiopathic SSHL were enrolled and matched with 1,728 HD patients without SSHL by using propensity score matching at a ratio of 1:6. MAIN OUTCOME MEASURES: A multivariate Cox regression and a competing risk regression were used to evaluate mortality and atherosclerotic events. RESULTS: Results revealed a risk of mortality in HD patients with SSHL than in HD patients without SSHL (adjusted hazard ratios [aHRs] 2.22, 95% confidence interval [CI] 1.71-2.89). HD patients with SSHL had higher risks of hemorrhagic stroke (competing risk aHR 4.08, 95% CI 1.93-8.61), ischemic stroke (competing risk aHR 2.34, 95% CI 1.45-3.78), acute coronary syndrome, and peripheral arterial occlusive disease than did the HD patients without SSHL. CONCLUSION: This study is the first to signify that the risks of mortality and atherosclerotic complications in HD patients with new-onset SSHL are increased. Therefore, we should pay attention to risks of mortality and atherosclerotic events in HD patients with new-onset SSHL.

AB - OBJECTIVES: There are higher incidence of sudden sensorineural hearing loss (SSHL) in hemodialysis (HD) patients than in the general population. Long-term outcomes of HD patients with new-onset SSHL have yet to be investigated although SSHL is considered as an independent risk of cardiovascular diseases in the general population. We examined the risks of mortality and atherosclerotic events in HD patients with new-onset SSHL in Taiwan. STUDY DESIGN: Cohort study. METHODS: Using the Taiwan National Health Institutes Research Database, 105,243 HD patients were identified between 1997 and 2008. In total, 288 HD patients with a new diagnosis of idiopathic SSHL were enrolled and matched with 1,728 HD patients without SSHL by using propensity score matching at a ratio of 1:6. MAIN OUTCOME MEASURES: A multivariate Cox regression and a competing risk regression were used to evaluate mortality and atherosclerotic events. RESULTS: Results revealed a risk of mortality in HD patients with SSHL than in HD patients without SSHL (adjusted hazard ratios [aHRs] 2.22, 95% confidence interval [CI] 1.71-2.89). HD patients with SSHL had higher risks of hemorrhagic stroke (competing risk aHR 4.08, 95% CI 1.93-8.61), ischemic stroke (competing risk aHR 2.34, 95% CI 1.45-3.78), acute coronary syndrome, and peripheral arterial occlusive disease than did the HD patients without SSHL. CONCLUSION: This study is the first to signify that the risks of mortality and atherosclerotic complications in HD patients with new-onset SSHL are increased. Therefore, we should pay attention to risks of mortality and atherosclerotic events in HD patients with new-onset SSHL.

UR - http://www.scopus.com/inward/record.url?scp=85056566271&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056566271&partnerID=8YFLogxK

U2 - 10.1097/MAO.0000000000001967

DO - 10.1097/MAO.0000000000001967

M3 - Article

C2 - 30212427

AN - SCOPUS:85056566271

VL - 39

SP - 1241

EP - 1249

JO - Otology and Neurotology

JF - Otology and Neurotology

SN - 1531-7129

IS - 10

ER -